(RS)-S-(4-[4-((R)-2-hydroxy-1-methyl-ethylamino)-5-(1H-indazol-5-ylethynyl)-pyrimidin-2-ylamino]-phenyl)-S-methylsulfoximide | 1093848-23-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: (RS)-S-(4-[4-((R)-2-hydroxy-1-methyl-ethylamino)-5-(1H-indazol-5-ylethynyl)-pyrimidin-2-ylamino]-phenyl)-S-methylsulfoximide
• 英文别名: (2R)-2-[[5-[2-(1H-indazol-5-yl)ethynyl]-2-[4-(methylsulfonimidoyl)anilino]pyrimidin-4-yl]amino]propan-1-ol
• CAS: 1093848-23-7
• 化学式: C₂₃H₂₃N₇O₂S
• 分子量: 461.547
• InChiKey: OKFPTOFRBZLMDL-FJNJALAMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  33
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  148
• 氢给体数：
  5
• 氢受体数：
  8

文献信息

• ALKYNYLPYRIMIDINES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME
  申请人：Hartung Ingo

  公开号：US20090099219A1

  公开（公告）日：2009-04-16

  The invention relates to alkynylpyrimidines according to the general formula (I): in which A, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined in the claims, and salts, N-oxides, metabolites, solvates, tautomers and prodrugs thereof, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.

  本发明涉及一种按照通式（I）定义的炔基嘧啶化合物，其中A、R1、R2、R3、R4、R5和R6如权利要求所定义的，并且其盐、N-氧化物、代谢物、溶剂合物、互变异构体和前药，以及包含该炔基嘧啶化合物的制药组合物，制备该炔基嘧啶化合物的方法，以及用于制备治疗失调血管生长疾病或伴随失调血管生长的疾病的制药组合物的用途，其中该化合物有效干扰Tie2和VEGFR2信号传导。
• US8642611B2
  申请人：——

  公开号：US8642611B2

  公开（公告）日：2014-02-04